Carderock Capital Management Inc Edwards Lifesciences Corp Transaction History

Carderock Capital Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$82.37 - $107.29 $1.67 Million - $2.17 Million	-20,227 Reduced 37.02%	34,409 $2.84 Million
Q2 2022 Jul 21, 2022	SELL	$86.5 - $128.27 $845,970 - $1.25 Million	-9,780 Reduced 15.18%	54,636 $5.2 Million
Q1 2022 Apr 28, 2022	SELL	$101.96 - $128.34 $143,151 - $180,189	-1,404 Reduced 2.13%	64,416 $7.58 Million
Q4 2021 Jan 31, 2022	BUY	$106.37 - $130.68 $2.29 Million - $2.81 Million	21,521 Added 48.58%	65,820 $8.53 Million
Q3 2021 Oct 29, 2021	BUY	$102.91 - $122.75 $108,055 - $128,887	1,050 Added 2.43%	44,299 $5.02 Million
Q2 2021 Jul 30, 2021	SELL	$83.84 - $104.76 $220,750 - $275,833	-2,633 Reduced 5.74%	43,249 $4.48 Million
Q1 2021 May 07, 2021	BUY	$78.68 - $90.67 $3,934 - $4,533	50 Added 0.11%	45,882 $3.84 Million
Q4 2020 Feb 05, 2021	BUY	$71.69 - $91.23 $40,289 - $51,271	562 Added 1.24%	45,832 $4.18 Million
Q3 2020 Oct 27, 2020	BUY	$67.19 - $87.44 $146,407 - $190,531	2,179 Added 5.06%	45,270 $3.61 Million
Q2 2020 Aug 04, 2020	BUY	$57.54 - $76.95 $2.16 Million - $2.88 Million	37,491 Added 669.48%	43,091 $2.98 Million
Q1 2020 May 11, 2020	SELL	$52.41 - $81.0 $2,358 - $3,645	-45 Reduced 0.8%	5,600 $1.06 Million
Q4 2019 Feb 04, 2020	BUY	$71.7 - $82.09 $404,746 - $463,398	5,645 New	5,645 $1.32 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Carderock Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Carderock Capital Management Inc with notifications on news.